{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:04:57Z","timestamp":1792674297401,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Variability in patient response to anti-cancer drugs is currently addressed by relating genetic mutations to chemotherapy through precision medicine. However, practical benefits of precision medicine to therapy design are less clear. Even after identification of mutations, oncologists are often left with several drug options, and for some patients there is no definitive treatment solution. There is a need for model systems to help predict personalized responses to chemotherapeutics. We have microengineered 3D tumor organoids directly from fresh tumor biopsies to provide patient-specific models with which treatment optimization can be performed before initiation of therapy. We demonstrate the initial implementation of this platform using tumor biospecimens surgically removed from two mesothelioma patients. First, we show the ability to biofabricate and maintain viable 3D tumor constructs within a tumor-on-a-chip microfluidic device. Second, we demonstrate that results of on-chip chemotherapy screening mimic those observed in subjects themselves. Finally, we demonstrate mutation-specific drug testing by considering the results of precision medicine genetic screening and confirming the effectiveness of the non-standard compound 3-deazaneplanocin A for an identified mutation. This patient-derived tumor organoid strategy is adaptable to a wide variety of cancers and may provide a framework with which to improve efforts in precision medicine oncology.<\/jats:p>","DOI":"10.1038\/s41598-018-21200-8","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T10:28:02Z","timestamp":1517999282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening"],"prefix":"10.1038","volume":"8","author":[{"given":"Andrea R.","family":"Mazzocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiny A. P.","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Votanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2138-2453","authenticated-orcid":false,"given":"Aleksander","family":"Skardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"21200_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/1758834015591952","volume":"7","author":"NH Tran","year":"2015","unstructured":"Tran, N. H. et al. Precision medicine in colorectal cancer: the molecular profile alters treatment strategies. Therapeutic advances in medical oncology 7, 252\u2013262, https:\/\/doi.org\/10.1177\/1758834015591952 (2015).","journal-title":"Therapeutic advances in medical oncology"},{"key":"21200_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.seminoncol.2015.07.013","volume":"42","author":"G Miles","year":"2015","unstructured":"Miles, G., Rae, J., Ramalingam, S. S. & Pfeifer, J. Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors. Seminars in oncology 42, 713\u2013723, https:\/\/doi.org\/10.1053\/j.seminoncol.2015.07.013 (2015).","journal-title":"Seminars in oncology"},{"key":"21200_CR3","doi-asserted-by":"publisher","unstructured":"Bando, H. & Takebe, N. Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development. Japanese journal of clinical oncology, https:\/\/doi.org\/10.1093\/jjco\/hyv144 (2015).","DOI":"10.1093\/jjco\/hyv144"},{"key":"21200_CR4","first-page":"133","volume":"126","author":"DF Hayes","year":"2015","unstructured":"Hayes, D. F. & Schott, A. F. Personalized Medicine: Genomics Trials in Oncology. Transactions of the American Clinical and Climatological Association 126, 133\u2013143 (2015).","journal-title":"Transactions of the American Clinical and Climatological Association"},{"key":"21200_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0158-y","volume":"7","author":"MA Cantrell","year":"2015","unstructured":"Cantrell, M. A. & Kuo, C. J. Organoid modeling for cancer precision medicine. Genome Med. 7, 32, https:\/\/doi.org\/10.1186\/s13073-015-0158-y (2015).","journal-title":"Genome Med."},{"key":"21200_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176\u2013187, https:\/\/doi.org\/10.1016\/j.cell.2014.08.016 (2014).","journal-title":"Cell"},{"key":"21200_CR7","doi-asserted-by":"publisher","first-page":"e20887","DOI":"10.1371\/journal.pone.0020887","volume":"6","author":"S Bhattacharya","year":"2011","unstructured":"Bhattacharya, S., Zhang, Q., Carmichael, P. L., Boekelheide, K. & Andersen, M. E. Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One 6, e20887, https:\/\/doi.org\/10.1371\/journal.pone.0020887 (2011).","journal-title":"PLoS One"},{"key":"21200_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1087057104265040","volume":"9","author":"LA Kunz-Schughart","year":"2004","unstructured":"Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F. & Ebner, R. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 9, 273\u2013285, https:\/\/doi.org\/10.1177\/1087057104265040 (2004).","journal-title":"J Biomol Screen"},{"key":"21200_CR9","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1111\/j.1349-7006.2010.01723.x","volume":"101","author":"WJ Ho","year":"2010","unstructured":"Ho, W. J. et al. Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer science 101, 2637\u20132643, https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01723.x (2010).","journal-title":"Cancer science"},{"key":"21200_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/biot.201100290","volume":"6","author":"M Drewitz","year":"2011","unstructured":"Drewitz, M. et al. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol J 6, 1488\u20131496, https:\/\/doi.org\/10.1002\/biot.201100290 (2011).","journal-title":"Biotechnol J"},{"key":"21200_CR11","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1007\/s10439-015-1298-3","volume":"43","author":"A Skardal","year":"2015","unstructured":"Skardal, A., Devarasetty, M., Rodman, C., Atala, A. & Soker, S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng 43, 2361\u20132373, https:\/\/doi.org\/10.1007\/s10439-015-1298-3 (2015).","journal-title":"Ann Biomed Eng"},{"key":"21200_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","volume":"21","author":"D Huh","year":"2011","unstructured":"Huh, D., Hamilton, G. A. & Ingber, D. E. From 3D cell culture to organs-on-chips. Trends in Cell Biology 21, 745\u2013754, https:\/\/doi.org\/10.1016\/j.tcb.2011.09.005 (2011).","journal-title":"Trends in Cell Biology"},{"key":"21200_CR13","doi-asserted-by":"publisher","unstructured":"Ghaemmaghami, A. M., Hancock, M. J., Harrington, H., Kaji, H. & Khademhosseini, A. Biomimetic tissues on a chip for drug discovery. Drug Discov Today, https:\/\/doi.org\/10.1016\/j.drudis.2011.10.029 (2011).","DOI":"10.1016\/j.drudis.2011.10.029"},{"key":"21200_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/17460441.2014.886562","volume":"9","author":"A Polini","year":"2014","unstructured":"Polini, A. et al. Organs-on-a-chip: a new tool for drug discovery. Expert opinion on drug discovery 9, 335\u2013352, https:\/\/doi.org\/10.1517\/17460441.2014.886562 (2014).","journal-title":"Expert opinion on drug discovery"},{"key":"21200_CR15","doi-asserted-by":"publisher","first-page":"031001","DOI":"10.1088\/1758-5090\/7\/3\/031001","volume":"7","author":"A Skardal","year":"2015","unstructured":"Skardal, A., Devarasetty, M., Soker, S. & Hall, A. R. In situ patterned micro 3D liver constructs for parallel toxicology testing in a fluidic device. Biofabrication 7, 031001, https:\/\/doi.org\/10.1088\/1758-5090\/7\/3\/031001 (2015).","journal-title":"Biofabrication"},{"key":"21200_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1146\/annurev-pathol-012414-040418","volume":"10","author":"KH Benam","year":"2015","unstructured":"Benam, K. H. et al. Engineered in vitro disease models. Annual review of pathology 10, 195\u2013262, https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040418 (2015).","journal-title":"Annual review of pathology"},{"key":"21200_CR17","doi-asserted-by":"publisher","unstructured":"Skardal, A. et al. A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery. J Biomed Mater Res B Appl Biomater, https:\/\/doi.org\/10.1002\/jbm.b.33736 (2016).","DOI":"10.1002\/jbm.b.33736"},{"key":"21200_CR18","doi-asserted-by":"publisher","unstructured":"Skardal, A. et al. Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function. Biomaterials 33, 4565\u20134575, https:\/\/doi.org\/10.1016\/j.biomaterials.2012.03.034 (2012).","DOI":"10.1016\/j.biomaterials.2012.03.034"},{"key":"21200_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/jcb.21386","volume":"101","author":"GD Prestwich","year":"2007","unstructured":"Prestwich, G. D. Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem 101, 1370\u20131383 (2007).","journal-title":"J Cell Biochem"},{"key":"21200_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/ar7000827","volume":"41","author":"GD Prestwich","year":"2008","unstructured":"Prestwich, G. D. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem Res 41, 139\u2013148 (2008).","journal-title":"Acc Chem Res"},{"key":"21200_CR21","doi-asserted-by":"publisher","unstructured":"Prestwich, G. D., Liu, Y., Yu, B., Shu, X. Z. & Scott, A. 3-D culture in synthetic extracellular matrices: new tissue models for drug toxicology and cancer drug discovery. Adv Enzyme Regul 47, 196\u2013207, https:\/\/doi.org\/10.1016\/j.advenzreg.2006.12.012 (2007).","DOI":"10.1016\/j.advenzreg.2006.12.012"},{"key":"21200_CR22","doi-asserted-by":"publisher","unstructured":"Serban, M. A. & Prestwich, G. D. Modular extracellular matrices: solutions for the puzzle. Methods 45, 93\u201398, https:\/\/doi.org\/10.1016\/j.ymeth.2008.01.010 (2008).","DOI":"10.1016\/j.ymeth.2008.01.010"},{"key":"21200_CR23","doi-asserted-by":"publisher","unstructured":"Skardal, A., Devarasetty, M., Forsythe, S., Atala, A. & Soker, S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng, https:\/\/doi.org\/10.1002\/bit.25950 (2016).","DOI":"10.1002\/bit.25950"},{"key":"21200_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.actbio.2015.07.030","volume":"25","author":"A Skardal","year":"2015","unstructured":"Skardal, A. et al. A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs. Acta Biomater 25, 24\u201334, https:\/\/doi.org\/10.1016\/j.actbio.2015.07.030 (2015).","journal-title":"Acta Biomater"},{"key":"21200_CR25","doi-asserted-by":"publisher","unstructured":"Skardal, A. et al. Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink. J Vis Exp, https:\/\/doi.org\/10.3791\/53606 (2016).","DOI":"10.3791\/53606"},{"key":"21200_CR26","doi-asserted-by":"publisher","unstructured":"Skardal, A., Sarker, S. F., Crabbe, A., Nickerson, C. A. & Prestwich, G. D. The generation of 3-D tissue models based on hyaluronan hydrogel-coated microcarriers within a rotating wall vessel bioreactor. Biomaterials 31, 8426\u20138435, https:\/\/doi.org\/10.1016\/j.biomaterials.2010.07.047 (2010).","DOI":"10.1016\/j.biomaterials.2010.07.047"},{"key":"21200_CR27","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1309\/AJCPHSUJ15NEYMIP","volume":"130","author":"Y Takeshima","year":"2008","unstructured":"Takeshima, Y., Amatya, V. J., Kushitani, K. & Inai, K. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Am J Clin Pathol 130, 771\u2013779, https:\/\/doi.org\/10.1309\/AJCPHSUJ15NEYMIP (2008).","journal-title":"Am J Clin Pathol"},{"key":"21200_CR28","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","volume":"20","author":"C Doglioni","year":"1996","unstructured":"Doglioni, C. et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20, 1037\u20131046 (1996).","journal-title":"Am J Surg Pathol"},{"key":"21200_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2559.1998.00349.x","volume":"32","author":"MP Leers","year":"1998","unstructured":"Leers, M. P., Aarts, M. M. & Theunissen, P. H. E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 32, 209\u2013216 (1998).","journal-title":"Histopathology"},{"key":"21200_CR30","first-page":"827","volume":"141","author":"CL Collins","year":"1992","unstructured":"Collins, C. L. et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 141, 827\u2013833 (1992).","journal-title":"Am J Pathol"},{"key":"21200_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen, D. E. et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097\u20131112 (1998).","journal-title":"Oncogene"},{"key":"21200_CR32","doi-asserted-by":"publisher","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","volume":"8","author":"AH Shain","year":"2013","unstructured":"Shain, A. H. & Pollack, J. R. The spectrum of SWI\/SNF mutations, ubiquitous in human cancers. PLoS One 8, e55119, https:\/\/doi.org\/10.1371\/journal.pone.0055119 (2013).","journal-title":"PLoS One"},{"key":"21200_CR33","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947","volume":"21","author":"LM LaFave","year":"2015","unstructured":"LaFave, L. M. et al. Loss of BAP1 function leads to EZH2-dependent transformation. Nat Med 21, 1344\u20131349, https:\/\/doi.org\/10.1038\/nm.3947 (2015).","journal-title":"Nat Med"},{"key":"21200_CR34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/his.13123","volume":"70","author":"A Shinozaki-Ushiku","year":"2017","unstructured":"Shinozaki-Ushiku, A. et al. Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma. Histopathology 70, 722\u2013733, https:\/\/doi.org\/10.1111\/his.13123 (2017).","journal-title":"Histopathology"},{"key":"21200_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.apsb.2015.01.011","volume":"5","author":"M Sha","year":"2015","unstructured":"Sha, M. et al. DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis. Acta pharmaceutica Sinica. B 5, 188\u2013193, https:\/\/doi.org\/10.1016\/j.apsb.2015.01.011 (2015).","journal-title":"Acta pharmaceutica Sinica. B"},{"key":"21200_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MOP.0000000000000172","volume":"27","author":"J Glade Bender","year":"2015","unstructured":"Glade Bender, J., Verma, A. & Schiffman, J. D. Translating genomic discoveries to the clinic in pediatric oncology. Curr Opin Pediatr 27, 34\u201343, https:\/\/doi.org\/10.1097\/MOP.0000000000000172 (2015).","journal-title":"Curr Opin Pediatr"},{"key":"21200_CR37","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/annonc\/mdu478","volume":"25","author":"F Andre","year":"2014","unstructured":"Andre, F. et al. Prioritizing targets for precision cancer medicine. Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO 25, 2295\u20132303, https:\/\/doi.org\/10.1093\/annonc\/mdu478 (2014).","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"21200_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-genom-090413-025552","volume":"15","author":"S Roychowdhury","year":"2014","unstructured":"Roychowdhury, S. & Chinnaiyan, A. M. Translating genomics for precision cancer medicine. Annual review of genomics and human genetics 15, 395\u2013415, https:\/\/doi.org\/10.1146\/annurev-genom-090413-025552 (2014).","journal-title":"Annual review of genomics and human genetics"},{"key":"21200_CR39","doi-asserted-by":"publisher","unstructured":"Sohal, D. P. et al. Prospective Clinical Study of Precision Oncology in Solid Tumors. J Natl Cancer Inst 108, https:\/\/doi.org\/10.1093\/jnci\/djv332 (2015).","DOI":"10.1093\/jnci\/djv332"},{"key":"21200_CR40","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1039\/C4LC00173G","volume":"14","author":"GA Cooksey","year":"2014","unstructured":"Cooksey, G. A. & Atencia, J. Pneumatic valves in folded 2D and 3D fluidic devices made from plastic films and tapes. Lab Chip 14, 1665\u20131668, https:\/\/doi.org\/10.1039\/c4lc00173g (2014).","journal-title":"Lab Chip"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21200-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21200-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21200-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:27:47Z","timestamp":1671589667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21200-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21200"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21200-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"17 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2886"}}